Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-M Nogaret

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Revue Medicale De Bruxelles|March 1, 1992
[Breast-preserving treatment of breast cancer and peroperative curietherapy]J M Nogaret, I Lorent, R Batrouni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Expression of c-erbB2, TGF-beta 1 and pS2 genes in primary human breast cancersC G Delvenne, R A Winkler-Gol, M J Piccart, et al.
American Journal of Clinical Pathology|May 9, 2000
Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 casesD Gancberg, L Lespagnard, G Rouas, et al.
Breast Cancer Research and Treatment|September 26, 2009
Evaluation of the histological size of the sentinel lymph node metastases using RT-PCR assay: a rapid tool to estimate the risk of non-sentinel lymph node invasion in patients with breast cancerI Veys, S Majjaj, R Salgado, et al.
Critical Reviews in Oncology/Hematology|March 4, 2008
A significant proportion of elderly patients develop hormone-dependant "luminal-B" tumours associated with aggressive characteristicsV Durbecq, L Ameye, I Veys, et al.
Journal of the National Cancer Institute|April 18, 1990
Cisplatin combined with carboplatin: a new way of intensification of platinum dose in the treatment of advanced ovarian cancer. Belgian Study Group for Ovarian CarcinomaM J Piccart, J M Nogaret, L Marcelis, et al.
International Journal of Breast Cancer|July 11, 2014
Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the jules bordet instituteC Philippson, S Simon, C Vandekerkhove, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancerA Di Leo, J Crown, J M Nogaret, et al.
Breast Cancer Research and Treatment|January 7, 1999
Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagenF Darro, P Cahen, A Vianna, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 22, 2008
Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodesM D Martin Martinez, I Veys, S Majjaj, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Revue Medicale De Bruxelles|March 1, 1992
[Breast-preserving treatment of breast cancer and peroperative curietherapy]J M Nogaret, I Lorent, R Batrouni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Expression of c-erbB2, TGF-beta 1 and pS2 genes in primary human breast cancersC G Delvenne, R A Winkler-Gol, M J Piccart, et al.
American Journal of Clinical Pathology|May 9, 2000
Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 casesD Gancberg, L Lespagnard, G Rouas, et al.
Breast Cancer Research and Treatment|September 26, 2009
Evaluation of the histological size of the sentinel lymph node metastases using RT-PCR assay: a rapid tool to estimate the risk of non-sentinel lymph node invasion in patients with breast cancerI Veys, S Majjaj, R Salgado, et al.
Critical Reviews in Oncology/Hematology|March 4, 2008
A significant proportion of elderly patients develop hormone-dependant "luminal-B" tumours associated with aggressive characteristicsV Durbecq, L Ameye, I Veys, et al.
Journal of the National Cancer Institute|April 18, 1990
Cisplatin combined with carboplatin: a new way of intensification of platinum dose in the treatment of advanced ovarian cancer. Belgian Study Group for Ovarian CarcinomaM J Piccart, J M Nogaret, L Marcelis, et al.
International Journal of Breast Cancer|July 11, 2014
Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the jules bordet instituteC Philippson, S Simon, C Vandekerkhove, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancerA Di Leo, J Crown, J M Nogaret, et al.
Breast Cancer Research and Treatment|January 7, 1999
Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagenF Darro, P Cahen, A Vianna, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 22, 2008
Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodesM D Martin Martinez, I Veys, S Majjaj, et al.
Pageof 5